Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

227 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Peri-Interventional Triple Therapy with Dabigatran Modifies Vasomotion after Bare-Metal Stent Implantation in a Pig Coronary Artery Model.
Hemetsberger R, Farhan S, Lukovic D, Zlabinger K, Hajagos-Toth J, Bota J, Garcia-Garcia HM, Ay C, Samaha E, Gaspar R, Garamvölgyi R, Huber K, Spannbauer A, Gyöngyösi M. Hemetsberger R, et al. Among authors: gyongyosi m. J Pers Med. 2023 Jan 31;13(2):280. doi: 10.3390/jpm13020280. J Pers Med. 2023. PMID: 36836514 Free PMC article.
Use of abciximab prior to primary angioplasty in STEMI results in early recanalization of the infarct-related artery and improved myocardial tissue reperfusion - results of the Austrian multi-centre randomized ReoPro-BRIDGING Study.
Gyöngyösi M, Domanovits H, Benzer W, Haugk M, Heinisch B, Sodeck G, Hödl R, Gaul G, Bonner G, Wojta J, Laggner A, Glogar D, Huber K; ReoPro-BRIDGING Study Group. Gyöngyösi M, et al. Eur Heart J. 2004 Dec;25(23):2125-33. doi: 10.1016/j.ehj.2004.09.018. Eur Heart J. 2004. PMID: 15571828 Clinical Trial.
Clinical restenosis after coronary stent implantation is associated with the heme oxygenase-1 gene promoter polymorphism and the heme oxygenase-1 +99G/C variant.
Gulesserian T, Wenzel C, Endler G, Sunder-Plassmann R, Marsik C, Mannhalter C, Iordanova N, Gyöngyösi M, Wojta J, Mustafa S, Wagner O, Huber K. Gulesserian T, et al. Among authors: gyongyosi m. Clin Chem. 2005 Sep;51(9):1661-5. doi: 10.1373/clinchem.2005.051581. Epub 2005 Jul 14. Clin Chem. 2005. PMID: 16020495
Platelet activation and high tissue factor level predict acute stent thrombosis in pig coronary arteries: prothrombogenic response of drug-eluting or bare stent implantation within the first 24 hours.
Gyöngyösi M, Strehblow C, Sperker W, Hevesi A, Garamvölgyi R, Petrási Z, Pavo N, Ferdinandy P, Csonka C, Csont T, Sylvèn C, Declerck PJ, Pavo I Jr, Wojta J, Glogar D, Huber K. Gyöngyösi M, et al. Thromb Haemost. 2006 Aug;96(2):202-9. doi: 10.1160/th06-03-0178. Thromb Haemost. 2006. PMID: 16894465
Effect of timing of clopidogrel administration on 30-day clinical outcomes: 300-mg loading dose immediately after coronary stenting versus pretreatment 6 to 24 hours before stenting in a large unselected patient cohort.
Szük T, Gyöngyösi M, Homorodi N, Kristóf E, Király C, Edes IF, Facskó A, Pavo N, Sodeck G, Strehblow C, Farhan S, Maurer G, Glogar D, Domanovits H, Huber K, Edes I. Szük T, et al. Among authors: gyongyosi m. Am Heart J. 2007 Feb;153(2):289-95. doi: 10.1016/j.ahj.2006.10.030. Am Heart J. 2007. PMID: 17239691 Clinical Trial.
Prediction of clinical outcome in patients with non-ST-elevation acute coronary syndrome (NSTE-ACS) using the TIMI risk score extended by N-terminal pro-brain natriuretic peptide levels.
Jarai R, Iordanova N, Jarai R, Jarai F, Raffetseder A, Woloszczuk W, Gyöngyösi M, Geyer G, Wojta J, Huber K. Jarai R, et al. Among authors: gyongyosi m. Wien Klin Wochenschr. 2007;119(21-22):626-32. doi: 10.1007/s00508-007-0892-2. Wien Klin Wochenschr. 2007. PMID: 18043882
227 results